Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19

DDI resources for investigational medications like ensitrelvir, with high DDI potential, are crucial for safe conduct of clinical trials. Effective implementation requires a multidisciplinary, iterative approach that incorporates real-time feedback from trial sites.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-06-11
DOI
https://doi.org/10.1093/ofid/ofaf327
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19

Nayon Kang, Joshua P Havens, Courtney Vail Fletcher, Phiona Kaweesi Nabaggala et al.
Open Forum Infectious Diseases
COVID-19 Clinical Research Studies
article

Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19

Nayon Kang, Joshua P Havens, Courtney Vail Fletcher, Phiona Kaweesi Nabaggala, Page Crew, Adit A. Ginde, Lianne Siegel, Jason V. Baker, Shikha Vasudeva, Anne Davis‐Karim, Birgit Grund, Sho Saito, Derek W. Russell, Alfredo J Mena Lora, Ryosuke Shimizu, Alpha Diallo, Katrina Harper, Ahmad Mourad, Marcelo Losso, Kyle C. Molina, Mina Pak, Jacqueline Nordwall, Lucy Chung
article en

Abstract

DDI resources for investigational medications like ensitrelvir, with high DDI potential, are crucial for safe conduct of clinical trials. Effective implementation requires a multidisciplinary, iterative approach that incorporates real-time feedback from trial sites.

Open Forum Infectious DiseasesVol. 12(7)
University of Minnesota (US), Nebraska Medical Center (US), Duke University (US), University of Minnesota System (US), University of Alabama at Birmingham (US), University of Illinois Chicago (US), Clinical Research Institute (US), The Coordinating Center (US), National Center for Global Health and Medicine (JP), Hospital Ramos Mejía (AR), Agence Nationale de Recherches sur le Sida et les Hépatites Virales (FR), Shionogi (Japan) (JP), Shionogi (United States) (US), National Institute of Allergy and Infectious Diseases (US), Minnesota Department of Health (US), Hennepin Healthcare Research Institute (US), University of Nebraska Medical Center (US), The University of Texas Southwestern Medical Center (US), Uganda Virus Research Institute (UG), University of Colorado Denver (US)
Norges Idrettshøgskole, National Institutes of Health, Instituto Nacional do Câncer, Ministério da Saúde, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 83%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.